July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Induced pluripotent stem cells promote retinal ganglion cell survival after transplant
Author Affiliations & Notes
  • Suqian Wu
    Department of Ophthalmology & Visual Science, Eye, Ear, Nose & Throat Hospital, Fudan University, Shanghai, Shanghai, China
    Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California, United States
  • Kun-Che Chang
    Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California, United States
  • Michael Nahmou
    Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California, United States
  • Jeffrey L Goldberg
    Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California, United States
  • Footnotes
    Commercial Relationships   Suqian Wu, None; Kun-Che Chang, None; Michael Nahmou, None; Jeffrey Goldberg, None
  • Footnotes
    Support  China Scholarship Council (201606100222); BrightFocus Foundation; Research to Prevent Blindness, Inc.; National Eye Institute (P30-EY026877)
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6110. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Suqian Wu, Kun-Che Chang, Michael Nahmou, Jeffrey L Goldberg; Induced pluripotent stem cells promote retinal ganglion cell survival after transplant. Invest. Ophthalmol. Vis. Sci. 2018;59(9):6110.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To identify the neuroprotective effects of human induced pluripotent stem cells (iPSCs) on grafted mouse retinal ganglion cells (RGCs) after transplantation.

Methods : For in vitro studies, human iPSCs were either directly co-cultured with mouse RGCs or plated in hanging inserts above a RGC culture for 1 week. For ex vivo studies, RGCs and iPSCs were dropped onto the inner surface of an adult rat retina explant and cultured for 1 week. For in vivo studies, RGCs were intravitreally injected, with iPSCs either intravitrally co-injected or subretinally injected, into an adult rat eye 1 week before sacrifice and retina dissection.

Results : A dose-dependent increase of RGC survival rate was found in RGC-iPSC direct co-cultures, while RGC-iPSC indirect co-cultures also showed a similar RGC protective effect, but to a lesser extent than a direct co-culture. Almost 5 times RGC survival was also identified from RGC-iPSC co-transplantations both ex vivo and in vivo. In addition, RGCs from the co-transplantation was found to double the neurite length per grafted live RGC than RGC-only transplants in vivo.

Conclusions : Human iPSCs promote transplanted RGC survival and neurite extension, which may be through secretion of neuroprotective compounds.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×